<code id='ECDEBA253A'></code><style id='ECDEBA253A'></style>
    • <acronym id='ECDEBA253A'></acronym>
      <center id='ECDEBA253A'><center id='ECDEBA253A'><tfoot id='ECDEBA253A'></tfoot></center><abbr id='ECDEBA253A'><dir id='ECDEBA253A'><tfoot id='ECDEBA253A'></tfoot><noframes id='ECDEBA253A'>

    • <optgroup id='ECDEBA253A'><strike id='ECDEBA253A'><sup id='ECDEBA253A'></sup></strike><code id='ECDEBA253A'></code></optgroup>
        1. <b id='ECDEBA253A'><label id='ECDEBA253A'><select id='ECDEBA253A'><dt id='ECDEBA253A'><span id='ECDEBA253A'></span></dt></select></label></b><u id='ECDEBA253A'></u>
          <i id='ECDEBA253A'><strike id='ECDEBA253A'><tt id='ECDEBA253A'><pre id='ECDEBA253A'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:915
          Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

          WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

          The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

          advertisement

          But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          Eating disorder hotline's move to chatbot carried cost for volunteers

          AdobeEarlythisspring,dozensofvolunteersfieldingrequestsfrompeoplestrugglingwitheatingdisorders—manyo